Journal Home
Search for

Volume 90, Issue 11, Pages 1829-1838 (November 2009)


View previous. 7 of 31 View next.

Novel Applications of Ultrasound Technology to Visualize and Characterize Myofascial Trigger Points and Surrounding Soft Tissue

Presented in part to the 30th Annual International Conference of the Institute for Electrical and Electronics Engineers, Engineering in Medicine and Biology Society, August 20–24, 2008, Vancouver, BC, Canada, and the 69th Annual Assembly of the American Academy of Physical Medicine and Rehabilitation, November 20–23, 2008, San Diego, CA.

Siddhartha Sikdar, PhDaCorresponding Author Informationemail address, Jay P. Shah, MDc, Tadesse Gebreab, BSc, Ru-Huey Yen, BSc, Elizabeth Gilliams, BSc, Jerome Danoff, PT, PhDc, Lynn H. Gerber, MDbc

Abstract 

Sikdar S, Shah JP, Gebreab T, Yen R-H, Gilliams E, Danoff J, Gerber LH. Novel applications of ultrasound technology to visualize and characterize myofascial trigger points and surrounding soft tissue.

Objective

To apply ultrasound (US) imaging techniques to better describe the characteristics of myofascial trigger points (MTrPs) and the immediately adjacent soft tissue.

Design

Four sites in each patient were labeled based on physical examination as active myofascial trigger points (A-MTrPs; spontaneously painful), latent myofascial trigger points (L-MTrPs; nonpainful), or normal myofascial tissue. US examination was performed on each subject by a team blinded to the physical findings. A 12∼5MHz US transducer was used. Vibration sonoelastography (VSE) was performed by color Doppler variance imaging while simultaneously inducing vibrations (∼92Hz) with a handheld massage vibrator. Each site was assigned a tissue imaging score as follows: 0, uniform echogenicity and stiffness; 1, focal hypoechoic region with stiff nodule; 2, multiple hypoechoic regions with stiff nodules. Blood flow in the neighborhood of MTrPs was assessed using Doppler imaging. Each site was assigned a blood flow waveform score as follows: 0, normal arterial flow in muscle; 1, elevated diastolic flow; 2, high-resistance flow waveform with retrograde diastolic flow.

Setting

Biomedical research center.

Participants

Subjects (N=9) meeting Travell and Simons' criteria for MTrPs in a taut band in the upper trapezius.

Interventions

Not applicable.

Main Outcome Measures

MTrPs were evaluated by (1) physical examination, (2) pressure algometry, and (3) three types of US imaging including gray-scale (2-dimensional [2D] US), VSE, and Doppler.

Results

MTrPs appeared as focal, hypoechoic regions on 2D US, indicating local changes in tissue echogenicity, and as focal regions of reduced vibration amplitude on VSE, indicating a localized, stiff nodule. MTrPs were elliptical, with a size of .16±.11cm2. There were no significant differences in size between A-MTrPs and L-MTrPs. Sites containing MTrPs were more likely to have a higher tissue imaging score compared with normal myofascial tissue (P<.002). Small arteries (or enlarged arterioles) near A-MTrPs showed retrograde flow in diastole, indicating a highly resistive vascular bed. A-MTrP sites were more likely to have a higher blood flow score compared with L-MTrPs (P<.021).

Conclusions

Preliminary findings show that, under the conditions of this investigation, US imaging techniques can be used to distinguish myofascial tissue containing MTrPs from normal myofascial tissue (lacking trigger points). US enables visualization and some characterization of MTrPs and adjacent soft tissue.

a Department of Electrical and Computer Engineering, George Mason University, Fairfax, VA

b Center for the Study of Chronic Illness and Disability, George Mason University, Fairfax, VA

c Rehabilitation Medicine Department, National Institutes of Health, Bethesda, MD

Corresponding Author InformationCorrespondence to Siddhartha Sikdar, PhD, Department of Electrical and Computer Engineering, George Mason University, 4400 University Dr, MS 1G5, Fairfax, VA 22030

 Supported by the Intramural Research Program, National Institutes of Health (NIH), and the Clinical Center and Office of the Director, NIH.

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.

PII: S0003-9993(09)00393-1

doi:10.1016/j.apmr.2009.04.015


View previous. 7 of 31 View next.